Track Regencell Bioscience Holdings Limited Ordinary Shares — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Regencell Bioscience Holdings Limited Ordinary Shares RGC · Stock Open Regencell Bioscience Holdings Limited Ordinary Shares in new tab

18.83 USD
EPS
-0.01
P/B
11575.00
ROE
-177.66
Beta
1.87
Loading chart...
Key Metrics
Earnings dateJune 15, 2026
EPS-0.01
Book Value0.00
Price to Book11575.00
Debt/Equity31.68
% Insiders88.379%

DCF Valuation

Tweak assumptions to recompute fair value for Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Regencell Bioscience Holdings Limited Ordinary Shares Logo Regencell Bioscience Holdings Limited Ordinary Shares Analysis (RGC)

Hong Kong Health Care Official Website Stock

Is Regencell Bioscience Holdings Limited Ordinary Shares a good investment? Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is currently trading at 18.83 USD.

Earnings Schedule: Regencell Bioscience Holdings Limited Ordinary Shares is expected to release its next earnings report on June 15, 2026.

Investor FAQ

Does Regencell Bioscience Holdings Limited Ordinary Shares pay a dividend?

No, it does not currently pay a dividend.

What asset class is Regencell Bioscience Holdings Limited Ordinary Shares?

Regencell Bioscience Holdings Limited Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 15, 2026. The company currently has a trailing EPS of -0.01.

Company Profile

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Exchange Ticker
NMS (United States) RGC
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
2018
8.36 USD
Feb. 26, 2018 8.3600
2017
33.44 USD
Dec. 15, 2017 8.3600
Sept. 15, 2017 8.3600
June 15, 2017 8.3600
March 15, 2017 8.3600
2016
33.44 USD
Dec. 15, 2016 8.3600
Sept. 15, 2016 8.3600
June 16, 2016 8.3600
March 15, 2016 8.3600
2015
33.44 USD
Dec. 15, 2015 8.3600
Sept. 15, 2015 8.3600
June 12, 2015 8.3600
March 13, 2015 8.3600
2014
33.44 USD
Dec. 15, 2014 8.3600
Sept. 15, 2014 8.3600
June 13, 2014 8.3600
March 14, 2014 8.3600
2013
31.92 USD
Dec. 13, 2013 7.9800
Sept. 17, 2013 7.9800
June 14, 2013 7.9800
March 15, 2013 7.9800
2012
31.92 USD
Dec. 14, 2012 7.9800
Sept. 18, 2012 7.9800
June 15, 2012 7.9800
March 15, 2012 7.9800
2011
31.92 USD
Dec. 16, 2011 7.9800
Sept. 19, 2011 7.9800
June 15, 2011 7.9800
March 15, 2011 7.9800
2010
27.36 USD
Dec. 17, 2010 6.8400
Sept. 17, 2010 6.8400
June 15, 2010 6.8400
March 16, 2010 6.8400
2009
20.52 USD
Dec. 17, 2009 6.8400
Sept. 18, 2009 6.8400
June 16, 2009 6.8400
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion